Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 110 entries
View as:

Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis

Phase: N/A Priority: Normal
NCT ID: NCT00864318 Org: User:
Start: 03/13/09 End: 10/05/20 Due: 10/05/21

From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02863900 Org: User:
Start: 12/31/16 End: 12/31/19 Due: 12/31/20

Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05821231 Org: User:
Start: 12/12/23 End: 11/30/27 Due: 11/30/28

Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention

Phase: N/A Priority: Normal
NCT ID: NCT06599879 Org: User:
Start: 04/30/25 End: 12/31/29 Due: 12/31/30

Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03627026 Org: User:
Start: 06/11/19 End: 06/03/24 Due: 06/03/25

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

Phase: N/A Priority: Normal
NCT ID: NCT02857400 Org: User:
Start: 07/21/17 End: 08/30/22 Due: 08/30/23

Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03289286 Org: User:
Start: 11/17/17 End: 06/29/18 Due: 06/29/19

A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.

Phase: N/A Priority: Normal
NCT ID: NCT02240017 Org: User:
Start: 01/21/15 End: 07/15/19 Due: 07/15/20

SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05826509 Org: User:
Start: 08/10/23 End: 05/31/30 Due: 05/31/31

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

Phase: N/A Priority: Normal
NCT ID: NCT02856347 Org: User:
Start: 03/22/17 End: 12/20/20 Due: 12/20/21

Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04307277 Org: User:
Start: 10/09/20 End: 10/31/32 Due: 10/31/33

Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of Innovations

Phase: N/A Priority: Normal
NCT ID: NCT05865964 Org: User:
Start: 12/14/22 End: 12/13/25 Due: 12/13/26

Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT06589414 Org: User:
Start: 01/08/24 End: 10/31/26 Due: 10/31/27

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT00814021 Org: User:
Start: 04/30/09 End: 03/31/11 Due: 03/31/12

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT05151718 Org: User:
Start: 09/30/21 End: 09/30/25 Due: 09/30/26

Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00209989 Org: User:
Start: 10/31/05 End: 06/30/11 Due: 06/30/12

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06967961 Org: User:
Start: 06/30/25 End: 07/01/29 Due: 07/01/30

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04818125 Org: User:
Start: 03/31/21 End: 07/29/22 Due: 07/29/23

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA)

Phase: N/A Priority: Normal
NCT ID: NCT02866916 Org: User:
Start: 09/30/17 End: 06/30/20 Due: 06/30/21

Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01507506 Org: User:
Start: 03/15/11 End: 01/02/20 Due: 01/02/21

A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

Phase: N/A Priority: Normal
NCT ID: NCT03966651 Org: User:
Start: 04/17/23 End: 02/28/26 Due: 02/28/27

Evaluation of Low-Level Laser Therapy Efficacy in Pain Management of Grade 2 Oral Mucositis Induced by Radiotherapy or Chemoradiotherapy: a Study in Patients With Upper Aerodigestive Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03955224 Org: User:
Start: 03/31/21 End: 10/31/22 Due: 10/31/23

TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma

Phase: N/A Priority: Normal
NCT ID: NCT03293784 Org: User:
Start: 10/16/17 End: 08/10/23 Due: 08/10/24

Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02555748 Org: User:
Start: 11/17/15 End: 01/16/20 Due: 01/16/21

Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04513444 Org: User:
Start: 12/07/20 End: 02/28/26 Due: 02/28/27